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Abstract
Background: The only thing that world is most vigilant about, now, is COVID-19. An 
outbreak of a disease of a type of pneumonia, caused by group of coronavirus, has created 
havoc in around more than 180 countries and regions worldwide and has claimed numbers 
of lives around the globe. The virus was named SARS-COV-2 belongs to the family of 
coronaviruses, which is believed to have originated from bats. It was declared pandemic by 
the World Health Organization on March 11, 2020. It is seen that virus spreads by human-
to-human transmission. Aim: To combat this virus, numerous measures are being taken. 
Effective vaccine has not been available thus far. However, it is been noted that the disease 
subsides by the administration of antiviral drugs and this mode of treatment has high 
success rate. Importance of social responsibility and refraining from spreading medically 
and scientifically invalidated information needs to be emphasized. Conclusion: The 
novel coronavirus spread so rapidly that it has change the rhythm of the globe, its current 
and future consequences on socioeconomic status and health-care facilities going to be 
a challenge for the country. However, every country is facing the crisis based on their 
own possibilities, expertise, and hypotheses. Thus, there are different criteria for testing, 
estimation, and hospitalization of cases making it difficult to calculate the number of 
people affected by pandemic. This review article summarizes the information about 
the virus, epidemiology, prevalence, current status in India, and the future impact of it 
on various strata. Clinical Significance: The clinical symptoms of COVID-19 may vary 
from symptomatic to asymptomatic forms which is characterized by severe respiratory 
failure, cough, myalgia, and fever. It is difficult to differentiate COVID-19 from other viral 
infections, symptoms are changing day by day. The incubation period can last longer than 
2 weeks and it is possible that a very long incubation period could reflect double exposure. 
Suspected and confirmed cases should be treated in designated hospitals with effective 
isolation and protective conditions in a single room. Moreover, critical cases need to be 
admitted to the intensive care unit as soon as possible.
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Introduction
The prominence of a pandemic coronavirus in late 2019 alarmed 
populations across the globe.
In December 2019, a number of people were suffering from 
pneumonia in hospitals of Wuhan, Hubei Province, China, with 
unknown cause which attracted the global attention.[1] A deep 
genomic sequencing analysis was carried out from the region of 
lower respiratory tract and samples were identified as novel virus 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
which was causative agent for that observed pneumonia disease 
in January 2020.[2] The World Health Organization (WHO) 
declared the COVID-19 to be a Public Health Emergency of 
International Concern. It was declared pandemic by the WHO 
by the March 11, 2020, due to increase in number with 118,000 
cases and over 4000 deaths in 114 countries. However, vaccines 
are not available against SARS-CoV-2 or any specific therapeutic 
drugs for this communicable disease.
COVID-19 was named in early 2020 whose occurrence was 
first identified in Wuhan, China, that damaged lower respiratory 
tract.[3] At present, there are globally COVID-19-positive cases 
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5,204,508 and 337,687 deceased in more than 180 countries.
Orthocoronavirinae in the family Coronaviridae, order 






It is a single positive-sense RNA virus with mutation rate 
more than DNA viruses and indicates a more effective survival 
adaption mechanism.[4] SARS-CoV-2 is part of a group of viruses 
which resemble a crown (corona), and it belongs to the species 
Betacoronavirus, as the Middle East respiratory syndrome 
coronavirus (MERS-CoV) and SARS-CoV.[5] It has crown-like 
structure because its envelope is surrounded by glycoprotein.
In India, the first case was reported on January 30, 2020, in 
Kerala, and then, the disease gained a foothold across the country 
by March 2020. In this review, we summarize the epidemiology, 
clinical features, diagnosis, management, and prevention of 
COVID-19 for future aspects.
Epidemology
On December 31, 2019, some unexplained cases of pneumonia 
were observed in Hubei, China, which were reported by the 
Health Commission of Hubei. A total number of patients were 
first reported was 27, which later increased to 41 on January 11, 
2020, with seven severe cases and one death. Most of the cases 
were found related to Huanan Seafood Wholesale Market. The 
Chinese health authority stated that those patients were first 
found negative for common respiratory viruses, but then were 
positive for a novel coronavirus. It was named by the WHO 
as the 2019 novel coronavirus (2019-nCoV).[6] According 
to Li et al., he suggested the human-to-human transmission 
phenomenon because some patients did not have travel history 
to Wuhan, China.[7] The first confirmed case of COVID-19 in 
India was diagnosed on January 30, 2020, in Kerala. He had the 
travel history from Wuhan, China, and he was quarantined for 
14 days. In the end of February, number increased to 3. The 
first three Indians tested positive for coronavirus were from 
Kerala. The number of confirmed cases is constantly increasing 
worldwide and a steep increase in cases is being observed in low-
income countries.[8] In India, total cases reached to 107 with 
two deaths by the end of March, while in April, the statistics 
were 33,000 cases and 1074 fatalities. However, each and every 
country is suffering from crisis based on their own possibilities, 
expertise, and hypotheses. Thus, every country has different 
criteria for laboratory testing and hospitalization of cases, which 
makes it difficult to calculate the number of people affected 
by pandemic.[9] Today, May 24, 2020, based on the WHO 
reports, in India, we have 131,868 confirmed cases and 3867 
deaths.[10] As per the statistics, the number of cases reported in 
various states of India is as follows: Maharashtra: 56,948, Tamil 
Nadu: 18,545, Delhi: 15,257, Gujarat: 15,195, Rajasthan: 7703, 
Madhya Pradesh: 7261, and Uttar Pradesh: 6991 [Figure 1].
Pathogenesis
SARS-CoV-2 is the seventh member of the family of CoVs that 
infect humans. There are four human CoVs present, that is,
i. HCoV-229E
ii. HCoV-NL63
iii. HCoV- OC43 
iv. HCoV-HKU1.
These are able to cause a upper respiratory tract infections 
(common cold), whereas SARS-COV and MERS-COV are 
responsible for atypical pneumonia.[7] This virus is RNA 
virus enveloped in positive strand with largest family of RNA 
genomes. The transcription of RNA works through the 
replication-transcription complex and it is organized in double-
membrane vesicles. However, termination of transcription 
occurs at transcription regulatory sequences which is located 
between the so-called open reading frames (ORFs) which work 
as templates for the production of subgenomic mRNAs.[11] In the 
atypical COV genome, at least six ORFs are present. The pp1a 
and pp1ab polypeptides that are processed by virally encoded 
chymotrypsin-like protease (3CLpro) or main protease (Mpro), 
as well as one or two papain-like proteases for producing 16 
non-structural proteins (nsps) were guided by ORF1a and 
ORF1b.[10] However, other ORFs encode for structural proteins, 
including envelope, membrane, spike, nucleocapsid proteins, 
and accessory proteicchains.[12,13] The genetic sequence of 
SARS-CoV-2 is ≥70% similar to that SARS-CoV, and it has the 
capability to use same cell entry receptor (ACE2) as SARS-CoV 
to infect humans.[14,15] Spike [S] protein, a type I transmembrane 
glycoprotein, helps virus to enter into host body.[16] SARS-CoV-2 
gets replicates very rapidly after entry into alveolar epithelial cells 
which further triggers a strong immune response, resulting into 
cytokine storm syndromes and pulmonary tissue damage.[7]
Cytokine storm syndromes, also known as hypercytokinemia, 
are a group of disorders and are important causes of acute 
respiratory distress syndrome (ARDS) and multiple organ 
failure.[17-19] The protagonist of this storm is interleukin 6 (IL-6), 
which is produced by activated leukocytes.[20] IL-6 also increases 







Figure 1: Pie chart depicting percentage of total number of cases 
and deaths as of May 2020
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role in thermoregulation, bone maintenance, and functionality 
of the central nervous system.[21] In turn, IL-6 increases during 
various inflammatory and autoimmune disorders.[22] The 
pathogenesis of coronavirus in humans and animals is primarily 
due to:
a. DPP4 [dipeptidyl peptidase-4] mediated mechanism
b. Papain such as protease PLpro-mediated mechanism
c. Accessory proteins such as p4a and membrane M protein-
mediated mechanism.
A study by Diao et al., Wang et al., Tan et al., Chen et al., Liu 
et al., and Ning et al. has suggested that CoVs are primarily due 
to three mechanisms, such as DPP4 [dipeptidyl peptidase-4] 
mediated mechanism, papain such as protease PLpro-mediated 
mechanism, and accessory proteins such as p4a and membrane 
M protein-mediated mechanism.[23] ARDS decreased immune 
function and secondary infection further worsens respiratory 
failure.[24]
Clinical Manifestation
The clinical symptoms of COVID-19 may vary from 
symptomatic to asymptomatic forms which is characterized 
by severe respiratory failure that needs proper mechanical 
ventilation and support in an intensive care unit (ICU), to 
multiorgan and systemic manifestations in terms of sepsis, septic 
shock, and multiple organ dysfunction syndromes.[25] Symptoms 
vary from person to person suffering from COVID-19, following 
an incubation period of 1–14 to 21 days. The WHO has reported 
an incubation period for COVID-19 between 2 and 10 days. 
However, some literature suggest that the incubation period 
can last longer than 2 weeks which may lead to reflect double 







Recently, COVID-19 symptoms were also seen related to 
eyes. It is difficult to differentiate COVID-19 from other viral 
infections on the basis of symptoms. It is being noted that day-
by-day symptoms are changing. The patients with symptoms 
may have fever or no fever, whereas asymptomatic patients can 
also spread SARS-CoV-2 among humans.
Diagnosis and Management
The diagnosis of COVID-19 can be confirmed by performing 
several tests. They include real-time fluorescence test (RT-
PCR), throat swabs, secretions of the lower respiratory tract, and 
computed tomography imaging. Enzyme-linked immunosorbent 
assay kits for detection of IgM and IgG antibodies toward 
nucleocapsid (N) and other SARS-CoV2 proteins have also 
been available more recently.[27] General treatment should 
be given which includes bed rest, supportive and nutritional 
treatments, maintaining a constant internal environment (water, 
electrolytes, and other internal environment factors), and 
continuous monitoring of vital signs (heart rate, pulse, blood 
pressure, oxygen saturation, respiratory rate, etc.). As such, 
antiviral treatment is not recommended for COVID-19, and 
no vaccine is currently available.[28] Although, scientist around 
the world is working on potential treatment and vaccines for 
COVID-19.
Management of COVID-19 involves antipyretic, that 
is, paracetamol and antiviral therapy, namely, interferon-
alpha, lopinavir/ritonavir (Kaletra), ribavirin, chloroquine, 
arbidol (umifenovir), and remdesivir. Oxygen therapy is being 
administered for the patients with severe respiratory disease. 
Conservative management is the first and only line of treatment 
with antibiotic therapy during early and later stages. The main 
pharmacological experimental options are glucocorticoids, 
remdesivir, chloroquine and hydroxychloroquine (mainly 
in combination with azithromycin) tocilizumab, lopinavir-
ritonavir, baricitinib, nonsteroidal anti-inflammatory drugs, and 
angiotensin-converting enzyme.
Suspected and confirmed cases should be treated in 
designated hospitals with effective isolation and protective 
conditions in a single room. Moreover, critical cases need to be 
admitted to the ICU as soon as possible.
Prevention
If nation has to deal with COVID-19 then prevention is so far 
the best method to reduce the impact of it. The WHO has given 
some protocols for COVID-19 as preventive measures.
These are as follows: To wear face masks, to wash hands 
regularly with soap or disinfection with hand sanitizer containing 
at least 60% alcohol, to cover coughs and sneezes with tissue, to 
avoid contact with infected people, to maintain an appropriate 
distance from people, and to refrain from touching eyes, nose, 
and mouth with unwashed hands.
They have recommended avoiding movement to high-risk 
regions, contact with individuals who are asymptomatic and 
the consumption of meat from places with known COVID-19 
outbreak.[29]
It should be ensured that people follow good respiratory 
hygiene, thereby protecting themselves from the virus. It is 
advised to stay safe at home and make themselves self-isolate 
even with minor symptoms such as cold, cough, headache, 
and mild fever until recovery. It is of utmost importance to, be 
updated on the information from government sources, such as 
the WHO, local and national health authorities.
Current Scenario in India
India represents one of the most unique countries in terms of 
diversity and disparity. While instituting uniform COVID-19 
measures and policies, an array of occupational, cultural, 
Dubey, et al. Outbreak of COVID19: Current status and consequences
4
educational, and economic issue has come up. There are also 
challenges related to types of housing and living, as well as 
distribution and availability of health-care facilities. The approach 
befitting a country like India would be TIP – Testing and Tracing 
contacts, Isolation of confirmed and suspected cases as well as 
high-risk contacts, and Precautions and Preventive measures 
for the population. India is a country of diverse beliefs, cultures, 
systems, and practices. With digitalization and widespread access 
to social media, a gamut of information is available, shared, 
and spread in a short period which can not only adversely 
impact positive efforts but also lead to misplaced fear, panic, 
and undesirable social repercussions. Therefore repeatedly, the 
importance of social responsibility and refraining from spreading 
medically and scientifically invalidated information needs to be 
emphasized. The Ministry of Health and Family Welfare of India 
along with the Indian Council of Medical Research (ICMR) has 
one of the most updated online sites with all information, FAQs, 
advisories, and recommendations in place for COVID-19. In 
addition, the Aarogya setu app, launched for installation in smart 
phones aids calculation of the risk of COVID based on parameters 
of positive cases in the vicinity, enabling us to take necessary 
steps for assessing risk of spread of COVID-19 infection, As of 
May 14, 2020, India has enhanced its testing capacity to conduct 
100,000 tests per day, with more than 500 laboratories including 
359 government and 145 private in the country [Graph 1]. As of 
May 17, 2020, there were 53,946 active cases, 34,109 recovered/
discharged/migrated, and 2872 deaths in India.
ICMR has fast tracked the global “Solidarity” trial launched 
by the WHO and has accelerated the clinical trial in finding 
an effective treatment for COVID-19. ICMR-NIV, Pune, has 
developed a IgG ELISA test for antibody detection for SARS-
CoV-2. Further, the IgG test kit produced by ICMR-NIV, has 
sensitivity and specificity of 98.7% and 100%, respectively.[30]
Since March 2020, multiple cases of patients with travel history 
were reported and significantly increasing in country, and this 
could be because of human-to-human transmission. At present, 
India is going through a tough phase, country in under lockdown 
since March 25, 2020, all the amenities such as school, colleges, 
restaurants, gym, shopping malls, recreation centers, Indian 
railways, and airports were closed due to the spread of pandemic 
COVID-19 on a large scale. These amenities have been converted 
into quarantine place to handle an anticipated increased number of 
cases. Some hospitals have been converted exclusively into isolation 
ward for COVID-19-positive patients. An intensive campaign was 
done and ministry of health affairs has issued guidelines against 
COVID-19 such as personal hygiene, surveillance, contact tracing, 
quarantine, diagnosis, laboratory tests, and management. They also 
advised to peoples to avoid mass gatherings.
Arogya setu app was launched and developed by the 
Government of India to connect with the people of India in fight 
against COVID-19. The aim of app is to advance the initiatives 
of the Government of India, particularly the health department, 
in proactively reaching out to and informing the users of the 
app regarding risks and relevant advisories pertaining to the 
containment of COVID-19.
Consequences
On the wake of COVID-19, the global scenario is surely going 
to be fragile and will undergo a drastic transformation. There are 
number of various future scenarios depending on how the people 
and government deal with it. The aftermath of it would surely 
not only be on people but also on health sector. It also covers a 
social aspect and an economical too. The worldwide economy 
has been stumbled upon. It is now coping up by barbarism, spike 
in unemployment, and liquidity by the banks, state capitalism, 
and etcetera.
Looking forward, people have restricted themselves due to 
lockdown which is quite an effective measure to curb COVID-19 
but might as well affect people mentally and socially. There is 
uncertainty about tomorrow, about the health and safety of our 
families, friends, and loved ones.
Graph 1: Graph depicting total test done by ICMR till May 17
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Conclusion
This pandemic continues ti spread across the world following 
a trajectory that is difficult to predict. The health and 
socioeconomic policies adopted by different countries will 
determine the speed and strength of the recovery. People should 
follow the guidelines provided by the government and should 
restrict themselves and maintain social distancing.
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